Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs

Immunotherapeutic and targeted drugs improved survival of patients with metastatic melanoma. There is, however, a lack of evidence regarding their healthcare costs in clinical practice. The aim of our study was to provide insight into real-world healthcare costs of patients with metastatic cutaneous...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancers (Basel)
Main Authors: Leeneman, Brenda, Uyl-de Groot, Carin A., Aarts, Maureen J. B., van Akkooi, Alexander C. J., van den Berkmortel, Franchette W. P. J., van den Eertwegh, Alfons J. M., de Groot, Jan Willem B., Herbschleb, Karin H., van der Hoeven, Jacobus J. M., Hospers, Geke A. P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Suijkerbuijk, Karijn P. M., ten Tije, Albert J., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Wouters, Michel W. J. M., Haanen, John B. A. G., Franken, Margreet G.
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225943/
https://ncbi.nlm.nih.gov/pubmed/32325748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12041003
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍